-- 週一下午晚些時候，醫療保健類股下跌，紐約證券交易所醫療保健指數下跌0.2%，道富醫療保健精選行業SPDR ETF (XLV)下跌0.3%。 iShares生物技術ETF (IBB)下跌0.4%。 公司新聞方面，禮來公司(LLY)同意以最高23億美元的現金收購Ajax Therapeutics。該交易包括一筆預付款，以及根據臨床和監管里程碑的完成情況支付的後續款項。禮來公司股價下跌1.6%。 加拿大皇家銀行資本市場表示，由於投資者轉向管理式醫療，HCA Healthcare (HCA)可能至少在上半年面臨壓力，但3月的良好趨勢和交易所的正常走勢支撐了其長期前景。 HCA Healthcare股價上漲3.2%。 Organon (OGN) 股價應聲上漲 17%，此前該公司同意被印度太陽製藥工業公司以每股 14 美元的現金收購，交易對 Organon 的估值為 117.5 億美元。 根據路透社週六報道，Moderna (MRNA) 正面臨 CureVac 提起的專利侵權訴訟。 CureVac 指控 Moderna 的新冠疫苗 Spikevax 未經授權使用了其專有的 mRNA 技術。 Moderna 股價應聲下跌 4.7%。
Related Articles
Research
Research Alert: CFRA Retains Buy Opinion On Shares Of Waste Connections Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We update our 12-month target to CAD272 from CAD293, valuing shares with a multiple that is more in line with peers: 14.2x our estimated 2027 EBITDA outlook. We have maintained our 2026 and 2027 EPS forecasts at USD5.72 and USD6.49, respectively. WCN delivered strong Q1 results that exceeded expectations and aligned with our Buy thesis on shares. WCN's secondary market positioning, exposure to specialized waste streams, and focus on quality contracts is enabling solid waste pricing that is supporting both top- and bottom-line expansion. Solid waste core pricing of 6% supported growth, while the company strategically shed lower-margin volumes (down 1.5%), prioritizing profitability over volume - a trend we view favorably across the waste industry. Coupled with a more attractive valuation following a 17% one-year decline, we see upside in shares amid potential commodity price improvements, accretive M&A, and AI investments for operational benefits.
$WCN
Research
Research Alert: CFRA Retains Buy Opinion On Shares Of Waste Connections Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We update our 12-month target to $200 from $215, valuing shares with a multiple that is more in line with peers: 14.2x our estimated 2027 EBITDA outlook. We have maintained our 2026 and 2027 EPS forecasts at $5.72 and $6.49, respectively. WCN delivered strong Q1 results that exceeded expectations and aligned with our Buy thesis on shares. WCN's secondary market positioning, exposure to specialized waste streams, and focus on quality contracts is enabling solid waste pricing that is supporting both top- and bottom-line expansion. Solid waste core pricing of 6% supported growth, while the company strategically shed lower-margin volumes (down 1.5%), prioritizing profitability over volume - a trend we view favorably across the waste industry. Coupled with a more attractive valuation following a 17% one-year decline, we see upside in shares amid potential commodity price improvements, accretive M&A, and AI investments for operational benefits.
$WCN
Asia
Resolute Mining Confirms Mali Gold Mine Operating Without Interruption
Resolute Mining (ASX:RSG) confirmed that its Syama gold mine, located in southern Mali in the Sikasso region, continues to operate without interruption after recent reports regarding security incidents and unrest in Bamako and four other cities in central and northern parts of Mali, according to a Tuesday Australian bourse filing.There was no impact on the safety of personnel, supply chains, or production at this stage.The firm remains in regular contact with local authorities, security advisors, and in-country teams, and established security and travel protocols are in place, it added.
$ASX:RSG